drug development

Scientists work toward an elusive dream: a simple pill to treat Covid-19
Scientists work toward an elusive dream: a simple pill to treat Covid-19
Stat
COVID-19
drug development
Merck
Ridgeback Biotherapeutics
molnupiravir
Pfizer
Atea Pharmaceuticals
Flag link:
Alloy Therapeutics nabs a $75M series C to sow more seeds into the biotech ecosystem
Alloy Therapeutics nabs a $75M series C to sow more seeds into the biotech ecosystem
Fierce Biotech
Alloy Therapeutics
funding
drug discovery
drug development
Flag link:
Biden puts R&D investment at heart of $2T spending plan
Biden puts R&D investment at heart of $2T spending plan
Fierce Biotech
Joe Biden
R&D
pandemic
drug development
Flag link:
FDA grew too close to Biogen during Alzheimer’s drug development, doctors say
FDA grew too close to Biogen during Alzheimer’s drug development, doctors say
Pharmaforum
FDA
Biogen
drug development
aducanumab
Alzheimer's disease
Flag link:
How Gilead's and Merck's Surprise Partnership Will Shake Up the HIV Market
How Gilead's and Merck's Surprise Partnership Will Shake Up the HIV Market
Motley Fool
Gilead Sciences
Merck
HIV
drug development
Flag link:
COVID innovation lessons could be applied elsewhere
COVID innovation lessons could be applied elsewhere
RAPS.org
COVID-19
pandemic
innovation
drug development
vaccines
Flag link:
Boston Pharmaceuticals signs three-year agreement with GSK
Boston Pharmaceuticals signs three-year agreement with GSK
Pharmaceutical Business Review
GSK
Boston Pharmaceuticals
drug development
Flag link:
Anima Biotech, Takeda Collaborate To Develop MRNA Translation Modulators For Neurological Diseases
Anima Biotech, Takeda Collaborate To Develop MRNA Translation Modulators For Neurological Diseases
NASDAQ
Takeda
AnimaBiotech
MRNA
drug development
Flag link:
Stimulus bill packs a windfall for FDA and Covid-19 drug, vaccine developers
Stimulus bill packs a windfall for FDA and Covid-19 drug, vaccine developers
Endpoints
legislative
stimulus
COVID-19
vaccines
drug development
Flag link:
A busy year ahead for Parkinson’s disease
A busy year ahead for Parkinson’s disease
EP Vantage
Parkinson's Disease
drug development
AstraZeneca
Roche
Prothena
MeiraGTx
Annovis Bio
Sanofi
Alkahest
Peptron
SAGE Therapeutics
Flag link:
This Startup Just Raised $123 Million To Develop A New Way To Find Medicine
This Startup Just Raised $123 Million To Develop A New Way To Find Medicine
Forbes
Cellarity
startups
drug discovery
drug development
Flag link:
UCB taps Microsoft to accelerate drug discovery, clinical trials
UCB taps Microsoft to accelerate drug discovery, clinical trials
Fierce Biotech
UCB Pharma
Microsoft
drug development
drug discovery
artificial intelligence
Flag link:
Evox has big pharma partners. Now it has $95M to bring its own drugs to the clinic
Evox has big pharma partners. Now it has $95M to bring its own drugs to the clinic
MedCity News
Evox Therapeutics
exosomes
drug development
Flag link:
Pharma’s ambitious new antibiotic venture hires a CEO to fix a ‘broken’ pipeline
Pharma’s ambitious new antibiotic venture hires a CEO to fix a ‘broken’ pipeline
Stat
antibiotics
drug development
antibiotic resistance
AMR Action Fund
Henry Skinner
Flag link:
On the hunt for a better antibody, BigHat Biosciences debuts with $19M Series A to scale its 'wet lab' AI platform
On the hunt for a better antibody, BigHat Biosciences debuts with $19M Series A to scale its 'wet lab' AI platform
Endpoints
BigHat Biosciences
artificial intelligence
machine learning
drug development
antibodies
Flag link:
Drug Farm bags $56M to take novel hepatitis B drug into humans
Drug Farm bags $56M to take novel hepatitis B drug into humans
Fierce Biotech
Drug Farm
hepatitis B
funding
drug development
Flag link:
Sanofi flunks Parkinson's Phase II, axes handful of mid-stage programs in Q4 earnings
Sanofi flunks Parkinson's Phase II, axes handful of mid-stage programs in Q4 earnings
Endpoints
Sanofi
earnings
Parkinson's Disease
drug development
Flag link:
Pfizer bags rheumatoid arthritis rights to new immunotherapy class through deal with Imcyse
Pfizer bags rheumatoid arthritis rights to new immunotherapy class through deal with Imcyse
Fierce Biotech
Pfizer
Imcyse
rheumatoid arthritis
drug development
Flag link:
Roche chucks out phase 3 ipatasertib combo tests, midstage IL-33 asthma, BTKi arthritis trials in Q4 clear-out
Roche chucks out phase 3 ipatasertib combo tests, midstage IL-33 asthma, BTKi arthritis trials in Q4 clear-out
Fierce Biotech
Roche
earnings
cancer
autoimmune disease
drug development
Flag link:
GSK culls cancer, rare disease meds amid Q4 clear-out
GSK culls cancer, rare disease meds amid Q4 clear-out
Fierce Biotech
GSK
earnings
R&D
drug development
Flag link:

Pages